BMT CTN 1503 (STRIDE2): BMT for SCD

AddtoAny
Share:

WATCH THIS PAGE

Subscribe to be notified of changes or updates to this page.

4 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.

The purpose of this research study is to compare transplant (HCT/BMT) to standard of care treatment in young adults with SCD who have experienced complications. Once consented we would assess to see if you have a matched donor. Subjects who have a closely matched donor will undergo a bone marrow transplant. This is called the Donor Arm. Subjects who do not have a closely matched donor will receive the current standard of care for their disease. This is called the No Donor Arm. We will follow subjects in both arms for two years to evaluate outcomes over that time period.

Eligibility & Criteria

IRB #:
16-012854
Official Title:
BMT CTN 1503 (STRIDE2): A Study to Compare Bone Marrow Transplantation to Standard Care in Adolescents and Young Adults with Severe Sickle Cell Disease
Study Phase:
Pilot
Phase II
Eligible Age Range:
15 - 41 Years
Gender:
All
Study Categories: